AFFLUENT MEDICAL |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.71 EUR | -0.58% |
|
-5.00% | -7.32% |
| 04-25 | Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-13 | AFFLUENT MEDICAL : Invest Securities reiterates its opinion | CF |
| Sales 2023 | - | Sales 2024 * | - | Capitalization | 56.5M 52.69M 4.51B |
|---|---|---|---|---|---|
| Net income 2023 | -15M -13.99M -1.2B | Net income 2024 * | -19M -17.72M -1.52B | EV / Sales 2023 | - |
| Net Debt 2023 * | 10.73M 10.01M 856M | Net Debt 2024 * | 29.57M 27.58M 2.36B | EV / Sales 2024 * | - |
| P/E ratio 2023 * |
-3.03
x | P/E ratio 2024 * |
-3.2
x | Employees | 52 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 29.65% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -0.58% | ||
| 1 week | -5.00% | ||
| Current month | -2.01% | ||
| 1 month | -2.01% | ||
| 3 months | +1.48% | ||
| 6 months | +37.90% | ||
| Current year | -7.32% |
1 week
1.71
1.76
1 month
1.712.06
Current year
1.232.13
1 year
0.932.30
3 years
0.938.60
5 years
0.938.60
10 years
0.938.60
| Managers | Title | Age | Since |
|---|---|---|---|
Sébastien Ladet
CEO | Chief Executive Officer | - | 21/08/22 |
Luc Parisot
DFI | Director of Finance/CFO | - | - |
Benjamin Renault
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 65 | 26/03/18 | |
| Director/Board Member | - | 26/03/18 | |
| Director/Board Member | - | 18/01/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 1.71 | -0.58% | 805 |
| 29/04/24 | 1.72 | -0.58% | 2,810 |
| 26/04/24 | 1.73 | -1.70% | 2,169 |
| 25/04/24 | 1.76 | +1.15% | 767 |
| 24/04/24 | 1.74 | -1.14% | 2,150 |
Real-time Euronext Paris, April 30, 2024 at 12:10 pm
More quotes
Affluent Medical is specialized in the development and production of mini-invasive prostheses used for treating heart disease and urinary incontinence.
Calendar
25/09/2024
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.71
EUR
Average target price
3.367
EUR
Spread / Average Target
+96.88%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.32% | 56.43M | |
| +73.09% | 12.37B | |
| -18.39% | 7.96B | |
| +14.33% | 7.09B | |
| +4.77% | 5.83B | |
| +11.77% | 5.35B | |
| +29.65% | 4.63B | |
| -17.74% | 4B | |
| -35.92% | 2.41B | |
| +1.24% | 2B |
- Stock Market
- Equities
- AFME Stock
